Mumps virus inhibits migration of primary human macrophages toward a chemokine gradient through a TNF-alpha dependent mechanism

Virology

Volumn 433, Issue 1, 2012, Pages 245-252

  Briggs, Caitlin M ^a   Mayer, Anne E ^a   Parks, Griffith D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Macrophage; Paramyxovirus

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT COLONY STIMULATING FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULOTROPIN;

ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; CYTOPATHOGENIC EFFECT; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MACROPHAGE MIGRATION INHIBITION; MUMPS; MUMPS VIRUS; NONHUMAN; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS 5; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

CELL MIGRATION INHIBITION; CHEMOTAXIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MUMPS VIRUS; PRIMARY CELL CULTURE; RECEPTORS, CHEMOKINE; RESPIROVIRUS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUMPS VIRUS; PARAINFLUENZA VIRUS; PARAMYXOVIRIDAE;

EID: 84866152688     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.08.017     Document Type: Article

References (37)

1. Arimilli S., Alexander-Miller M.A., Parks G.D. A Simian Virus 5 (SV5) mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function. J. Virol. 2006, 8:3416-3427.
2. Assuncao-Miranda I., Bozza M.T., DaPoian A.T. Pro-inflammatory response resulting from Sindbis virus infection of human macrophages: implications for the pathogenesis of viral arthritis. J. Med. Virol. 2010, 82:164-174.
3. Baugh J.A., Bucala R. Macrophage migration inhibitory factor. Crit. Care Med. 2002, 30:S27-S35.
4. Briggs C.M., Holder R.C., Reid S.D., Parks G.D. Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutant. Microb. Infect. 2011, 13:359-368.
5. Calandra T., Rogers T. Macrophage migration inhibitory factor; a regulator of innate immunity. Nat. Rev. Immunol. 2003, 3:791-800.
6. Chi H., Barry S.P., Roth R.J., Wu J.J., Jones E.A., Bennett A.M., Flavell R.A. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphotase 1(MKP-1) in innate immune responses. Proc. Nat. Acad. Sci. USA 2006, 103:2274-2279.
7. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., Finberg R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 2003, 77:4588-4596.
8. Dillon P.J., Wansley E.K., Young V.A., Alexander-Miller M.A., Parks G.D. Exchange of P/V genes between two non-cytopathic simian virus 5 variants results in a recombinant virus that kills cells through death pathways that are sensitive to caspase inhibitors. J. Gen. Virol 2006, 87:3643-3648.
9. Dillon P.J., Parks G.D. A role for the P subunit of the paramyxovirus polymerase in limiting host cell antiviral responses. J. Virol. 2007, 81:11116-11127.
10. Flanagan T.D., Yoshida T., Cohen S. Production of macrophage migration inhibition factors by virus-infected cell cultures. Infect. Immun. 1973, 8:145-150.
11. Frascaroli G., Varani S., Blankenhorn N., Pretsch R., Bacher M., Leng L., Bucala R., Landini M.P., Mertens T. Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of cytoskeleton, and release of macrophage migration inhibitory factor. J. Immunol. 2009, 182:477-488.
12. Grimshaw M.J., Balkwill F.R. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation; a potential mechanism. Eur. J. Immunol. 2001, 31:480-489.
13. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2008, 8:533-544.
14. He B., Paterson R.G., Stock N., Durbin J.E., Durbin R.K., Goodbourn S., Randall R.E., Lamb R.A. Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-[beta] induction and interferon signaling. Virology 2002, 303:15-32.
15. Herriott M.J., Jiang H., Stewart C.A., Fast D.J., Leu R.W. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. J. Immunol. 1993, 150:4524-4531.
16. Holmes D.I., Zachary I.C. Vascular endothelial growth factor regulates stanniocalcin-1 expression via neutrophil-1-dependent regulation of KDR and synergism with fibroblast growth factor-2. Cell. Signal. 2007, 20:569-579.
17. Hviid A., Rubin S., Muhlemann K. Mumps. Lancet 2008, 371:932-944.
18. Johnson J.B., Capraro G.C., Parks G.D. Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses Simian Virus 5 and Mumps Virus. Virology 2008, 376:112-123.
19. Kim H.M., Lee Y.W., Lee K.J., Kim H.S., Cho S.W., van Rooijen N., Guan Y., Seo S.H. Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J. Virol. 2008, 82:4265-4274.
20. Lamb R.A., Parks G.D. Paramyxoviridae: the viruses and their replication. Fields Virology 2007, 1449-1496. Lippincott Williams and Wilkins Publishers, Philadelphia, Pa. 5th ed. B. Fields, D. Knipe, P. Howley. (Eds.).
21. Lehtonen A.H., Ahlfors H., Veckman V., Miettinen M., Lahesmaa R., Julkunen L. Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J. Leukoc. Biol. 2007, 82:710-720.
22. Lin G., Lamb R.A. The paramyxovirus simian virus 5V protein slows progression of the cell cycle. J. Virol. 2000, 74:9152-9166.
23. Manuse M.J., Parks G.D. Role for the Paramyxovirus genomic promoter in limiting host cell antiviral responses and cell killing. J. Virol. 2009, 83:9057-9067.
24. Manuse M.J., Parks G.D. TLR-3 dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5. Virology 2010, 397:231-241.
25. Monteclaro F.S., Charo I.F. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J. Biol. Chem. 1996, 271:19084-19092.
26. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
27. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. 2011, 11:723.
28. Neote K., DiGregorio D., Mak J.Y., Horuk R., Schall T.J. Molecular cloning, functional expression, and signaling characteristics of a CC chemokine receptor. Cell 1993, 72:415-425.
29. Pearson L.L., Castle B.E., Khery M.R. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways. Int. Immunol. 2001, 13:273-283.
30. Popa C., van Lieshout A.W., Roelofs M.F., Geurts-Moespot A., van Riel P.L., Calandra T., Sweep F.C., Radstake T.R. MIF production by dendritic cells is differentially regulated by toll-like receptors and increased during rheumatoid arthritis. Cytokine 2006, 36:51-56.
31. Rubin S.A., Afzal M.A. Neurovirulence safety testing of mumps vaccines-historical perspective and current status. Vaccine 2011, 29:2850-2855.
32. Rubin S.A., Link M.A., Sauder C.J., Zhang C., Ngo L., Rima B.K., Duprex W.P. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J. Virol. 2011, 86:615-620.
33. Salojin K.V., Owusu I.B., Millerchip K.A., Potter M., Platt K.A., Oravecz T. Essential role of MAPK phosphotase-1 in the negative control of innate immune responses. J. Immunol. 2006, 176:1899-1907.
34. Wansley E.K., Parks G.D. Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and induces cell death. J. Virol. 2002, 76:10109-10121.
35. Wijburg O.L., DiNatale S., Vadolas J., Van Rooijen N., Strugnell R.A. Alveolar macrophages regulate the induction of primary cytotoxic T-lymphocyte responses during influenza virus infection. J. Virol. 1997, 71:9450-9457.
36. Yoshida T., Flanagan T.D., Genco R.J., Cohen S. Virus-induced migration inhibitory activity in experimental mumps infection. Clin. Immunol. Immunopathol. 1974, 2:472-480.
37. Young V.A., Parks G.D. Simian virus 5 is a poor inducer of chemokine secretion from human lung epithelial cells: identification of viral mutants that activate interleukin-8 secretion by distinct mechanisms. J. Virol. 2003, 77:7124-7130.